Literature DB >> 20440294

CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection.

Javier Vega-Ramos1, Elisenda Alari-Pahissa, Juana Del Valle, Eugenio Carrasco-Marín, Enric Esplugues, Miquel Borràs, Carlos Martínez-A, Pilar Lauzurica.   

Abstract

Mouse infection with intracellular bacteria induces a potent inflammatory response that requires protective mechanisms to avoid infection-induced immune pathology. CD69 is expressed in all leukocytes during activation after infection with a wide range of microbial pathogens. This study explores the way in which CD69 affects cell activation after Listeria monocytogenes (Lm) infection and its effects on host protection. We show that infectivity and bacterial clearance capability are unaltered in CD69(-/-) peritoneal macrophages, bone marrow-derived macrophages and dendritic cells. We found no major altered cell populations in splenocytes of Lm-infected CD69(-/-) mice. However, an increase in the expression of Th1 cytokines was observed after infection, with increased production of type I and II interferon (IFN). In addition, CD69(-/-) splenocytes showed increased apoptosis, consistent with IFN enhancement of lymphocyte apoptosis in response to Lm infection. CD69(-/-) mice showed liver and spleen damage, and greatly increased susceptibility to Lm infection, compared with wild-type controls. Lm-specific T cells were decreased in CD69(-/-) mice even if T-cell cross-presentation and T-cell intrinsic priming response were not compromised. As listeriosis was increased as early as day 1 post-infection but CD69(-/-)RAG2(-/-) mice were more efficient at controlling Listeria, we propose that CD69 controls the cross-talk between innate components and lymphocytes. These results highlight a role for CD69 in preventing infection-induced immunopathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440294     DOI: 10.1038/icb.2010.62

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  23 in total

1.  CD69 guides CD4+ T cells to the seat of memory.

Authors:  Stephen P Schoenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

2.  NSOM/QD-based fluorescence-topographic image fusion directly reveals nano-spatial peak-valley polarities of CD69 and CD71 activation molecules on cell-membrane fluctuations during T-cell activation.

Authors:  Liyun Zhong; Zhun Zhang; Xiaoxu Lu; Dan Huang; Crystal Y Chen; Richard Wang; Zheng W Chen
Journal:  Immunol Lett       Date:  2011-06-15       Impact factor: 3.685

3.  Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma.

Authors:  Hui-ying Wang; Yu Dai; Jiao-li Wang; Xu-yan Yang; Xin-guo Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2015-07       Impact factor: 3.066

4.  CD69 Targeting Enhances Anti-vaccinia Virus Immunity.

Authors:  Laura Notario; Jennifer Redondo-Antón; Elisenda Alari-Pahissa; Almudena Albentosa; Magdalena Leiva; Daniel Lopez; Guadalupe Sabio; Pilar Lauzurica
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

5.  The Functional Requirement for CD69 in Establishment of Resident Memory CD8+ T Cells Varies with Tissue Location.

Authors:  Daniel A Walsh; Henrique Borges da Silva; Lalit K Beura; Changwei Peng; Sara E Hamilton; David Masopust; Stephen C Jameson
Journal:  J Immunol       Date:  2019-06-26       Impact factor: 5.422

6.  IRF6 Regulates Alternative Activation by Suppressing PPARγ in Male Murine Macrophages.

Authors:  Chuan Li; Wei Ying; Zheping Huang; Tyler Brehm; Andrew Morin; Anthony T Vella; Beiyan Zhou
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

7.  CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.

Authors:  Laura Notario; Elisenda Alari-Pahissa; Antonio de Molina; Pilar Lauzurica
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

Review 8.  CD69: from activation marker to metabolic gatekeeper.

Authors:  Danay Cibrián; Francisco Sánchez-Madrid
Journal:  Eur J Immunol       Date:  2017-06       Impact factor: 5.532

Review 9.  Is CD69 an effective brake to control inflammatory diseases?

Authors:  Roberto González-Amaro; José R Cortés; Francisco Sánchez-Madrid; Pilar Martín
Journal:  Trends Mol Med       Date:  2013-08-13       Impact factor: 11.951

10.  CD69 does not affect the extent of T cell priming.

Authors:  Elisenda Alari-Pahissa; Laura Notario; Elena Lorente; Javier Vega-Ramos; Ana Justel; Daniel López; José A Villadangos; Pilar Lauzurica
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.